Gupta, V. K. Bimatoprost Ophthalmic Solution (BOS) 0.3 Mg W V for 1 Open Trial of Long-Term Preventive Therapy of Migraine in 3 Patients With Pathophysiologic Shift from Brain to Eye. J Neurosci Neurol Disord 2023, 7, 134-154.